Are iron oxide nanoparticles safe? Current knowledge and future perspectives
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.18/4063 |
Resumo: | Due to their unique physicochemical properties, including superparamagnetism, iron oxide nanoparticles (ION) have a number of interesting applications, especially in the biomedical field, that make them one of the most fascinating nanomaterials. They are used as contrast agents for magnetic resonance imaging, in targeted drug delivery, and for induced hyperthermia cancer treatments. Together with these valuable uses, concerns regarding the onset of unexpected adverse health effects following exposure have been also raised. Nevertheless, despite the numerous ION purposes being explored, currently available information on their potential toxicity is still scarce and controversial data have been reported. Although ION have traditionally been considered as biocompatible - mainly on the basis of viability tests results - influence of nanoparticle surface coating, size, or dose, and of other experimental factors such as treatment time or cell type, has been demonstrated to be important for ION in vitro toxicity manifestation. In vivo studies have shown distribution of ION to different tissues and organs, including brain after passing the blood-brain barrier; nevertheless results from acute toxicity, genotoxicity, immunotoxicity, neurotoxicity and reproductive toxicity investigations in different animal models do not provide a clear overview on ION safety yet, and epidemiological studies are almost inexistent. Much work has still to be done to fully understand how these nanomaterials interact with cellular systems and what, if any, potential adverse health consequences can derive from ION exposure. |
id |
RCAP_8051fbcb0e6a7bcbdfaba23bce08d791 |
---|---|
oai_identifier_str |
oai:repositorio.insa.pt:10400.18/4063 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Are iron oxide nanoparticles safe? Current knowledge and future perspectivesIron Oxide NanoparticlesIn vivo StudiesIn vitro StudiesEpidemiological StudiesToxicityToxicologiaDue to their unique physicochemical properties, including superparamagnetism, iron oxide nanoparticles (ION) have a number of interesting applications, especially in the biomedical field, that make them one of the most fascinating nanomaterials. They are used as contrast agents for magnetic resonance imaging, in targeted drug delivery, and for induced hyperthermia cancer treatments. Together with these valuable uses, concerns regarding the onset of unexpected adverse health effects following exposure have been also raised. Nevertheless, despite the numerous ION purposes being explored, currently available information on their potential toxicity is still scarce and controversial data have been reported. Although ION have traditionally been considered as biocompatible - mainly on the basis of viability tests results - influence of nanoparticle surface coating, size, or dose, and of other experimental factors such as treatment time or cell type, has been demonstrated to be important for ION in vitro toxicity manifestation. In vivo studies have shown distribution of ION to different tissues and organs, including brain after passing the blood-brain barrier; nevertheless results from acute toxicity, genotoxicity, immunotoxicity, neurotoxicity and reproductive toxicity investigations in different animal models do not provide a clear overview on ION safety yet, and epidemiological studies are almost inexistent. Much work has still to be done to fully understand how these nanomaterials interact with cellular systems and what, if any, potential adverse health consequences can derive from ION exposure.This work was supported byXunta de Galicia (EM 2012/079), the project NanoToxClass (ERA ERA-SIINN/001/2013), and by TD1204 MODENA COST Action.ElsevierRepositório Científico do Instituto Nacional de SaúdeValdiglesias, VanessaFernández-Bertólez, NataliaKiliç, GözdeCosta, CarlaCosta, SolangeFraga, SoniaBessa, Maria JoaoPásaro, EduardoTeixeira, João PauloLaffon, Blanca2020-04-01T00:30:12Z2016-03-312016-03-31T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.18/4063engJ Trace Elem Med Biol. 2016 Dec;38:53-63. doi: 10.1016/j.jtemb.2016.03.017. Epub 2016 Mar 3110.1016/j.jtemb.2016.03.017info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-20T15:40:05Zoai:repositorio.insa.pt:10400.18/4063Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:38:49.574752Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Are iron oxide nanoparticles safe? Current knowledge and future perspectives |
title |
Are iron oxide nanoparticles safe? Current knowledge and future perspectives |
spellingShingle |
Are iron oxide nanoparticles safe? Current knowledge and future perspectives Valdiglesias, Vanessa Iron Oxide Nanoparticles In vivo Studies In vitro Studies Epidemiological Studies Toxicity Toxicologia |
title_short |
Are iron oxide nanoparticles safe? Current knowledge and future perspectives |
title_full |
Are iron oxide nanoparticles safe? Current knowledge and future perspectives |
title_fullStr |
Are iron oxide nanoparticles safe? Current knowledge and future perspectives |
title_full_unstemmed |
Are iron oxide nanoparticles safe? Current knowledge and future perspectives |
title_sort |
Are iron oxide nanoparticles safe? Current knowledge and future perspectives |
author |
Valdiglesias, Vanessa |
author_facet |
Valdiglesias, Vanessa Fernández-Bertólez, Natalia Kiliç, Gözde Costa, Carla Costa, Solange Fraga, Sonia Bessa, Maria Joao Pásaro, Eduardo Teixeira, João Paulo Laffon, Blanca |
author_role |
author |
author2 |
Fernández-Bertólez, Natalia Kiliç, Gözde Costa, Carla Costa, Solange Fraga, Sonia Bessa, Maria Joao Pásaro, Eduardo Teixeira, João Paulo Laffon, Blanca |
author2_role |
author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório Científico do Instituto Nacional de Saúde |
dc.contributor.author.fl_str_mv |
Valdiglesias, Vanessa Fernández-Bertólez, Natalia Kiliç, Gözde Costa, Carla Costa, Solange Fraga, Sonia Bessa, Maria Joao Pásaro, Eduardo Teixeira, João Paulo Laffon, Blanca |
dc.subject.por.fl_str_mv |
Iron Oxide Nanoparticles In vivo Studies In vitro Studies Epidemiological Studies Toxicity Toxicologia |
topic |
Iron Oxide Nanoparticles In vivo Studies In vitro Studies Epidemiological Studies Toxicity Toxicologia |
description |
Due to their unique physicochemical properties, including superparamagnetism, iron oxide nanoparticles (ION) have a number of interesting applications, especially in the biomedical field, that make them one of the most fascinating nanomaterials. They are used as contrast agents for magnetic resonance imaging, in targeted drug delivery, and for induced hyperthermia cancer treatments. Together with these valuable uses, concerns regarding the onset of unexpected adverse health effects following exposure have been also raised. Nevertheless, despite the numerous ION purposes being explored, currently available information on their potential toxicity is still scarce and controversial data have been reported. Although ION have traditionally been considered as biocompatible - mainly on the basis of viability tests results - influence of nanoparticle surface coating, size, or dose, and of other experimental factors such as treatment time or cell type, has been demonstrated to be important for ION in vitro toxicity manifestation. In vivo studies have shown distribution of ION to different tissues and organs, including brain after passing the blood-brain barrier; nevertheless results from acute toxicity, genotoxicity, immunotoxicity, neurotoxicity and reproductive toxicity investigations in different animal models do not provide a clear overview on ION safety yet, and epidemiological studies are almost inexistent. Much work has still to be done to fully understand how these nanomaterials interact with cellular systems and what, if any, potential adverse health consequences can derive from ION exposure. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-03-31 2016-03-31T00:00:00Z 2020-04-01T00:30:12Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.18/4063 |
url |
http://hdl.handle.net/10400.18/4063 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
J Trace Elem Med Biol. 2016 Dec;38:53-63. doi: 10.1016/j.jtemb.2016.03.017. Epub 2016 Mar 31 10.1016/j.jtemb.2016.03.017 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132126010933248 |